Brief: XVIVO Perfusion Appoints Dag Andersson President And CEO
April 29 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* SAID ON TUESDAY MAGNUS NILSSON HANDS OVER BATON TO DAG
ANDERSSON
AS PRESIDENT AND CEO OF XVIVO PERFUSION
* AT SAME TIME MAGNUS NILSSON WILL REMAIN AS SENIOR ADVISOR
TO
PRIMARILY WORK WITH RESEARCH AND DEVELOPMENT
* DAG ANDERSSON TAKES UP HIS NEW POSITION AS PRESIDENT AND
CEO ON
JUNE 1, 2020
Source text for Eikon: ID:nWkr8Tfxkn
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength